A detailed history of Ambassador Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ambassador Advisors, LLC holds 13,863 shares of JAZZ stock, worth $1.7 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
13,863
Previous 14,120 1.82%
Holding current value
$1.7 Million
Previous $1.51 Million 2.52%
% of portfolio
0.27%
Previous 0.28%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.57 - $116.37 $25,846 - $29,907
-257 Reduced 1.82%
13,863 $1.55 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $27,128 - $31,053
261 Added 1.88%
14,120 $1.51 Million
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $19,006 - $21,907
165 Added 1.2%
13,859 $1.67 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $317,642 - $378,080
2,780 Added 25.47%
13,694 $1.68 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $1.33 Million - $1.59 Million
10,914 New
10,914 $1.41 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ambassador Advisors, LLC Portfolio

Follow Ambassador Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ambassador Advisors, LLC with notifications on news.